Real-time enrollment status for this hypertrophic cardiomyopathy clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06347159 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hypertrophic Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Edgewise Therapeutics, Inc. |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06347159 is currently active_not_recruiting participants. This clinical trial study for hypertrophic cardiomyopathy is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Edgewise Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06347159 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06347159 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.